谷歌浏览器插件
订阅小程序
在清言上使用

Long-term Follow-Up and Exploratory Analysis of Lenvatinib in Patients with Metastatic or Recurrent Thymic Carcinoma: Results from the Multicenter, Phase 2 REMORA Trial

LUNG CANCER(2024)

引用 1|浏览24
关键词
Efficacy,Lenvatinib mesylate,Phase 2 clinical study,Relative dose intensity,Thymic carcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要